Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8794118 | Ophthalmology | 2018 | 9 Pages |
Abstract
Intravitreal bevacizumab therapy for ROP is associated with more rapid outer retinal thickening at the foveal center, whereas LPC is associated with earlier extrusion of the inner retinal layers and delayed development of the EZ at the foveal center. Long-term follow-up is needed to determine the visual significance of these findings.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ryan N. MD, Margaret BA, Oladipo E. BS, Alexis MS, Sergey PhD, Joseph PhD, Deborah M. MD, MS,